ethyl ester gave the key acid-aldehyde 7.3 This was then
coupled with excess diamine 8 using CDI (carbonyl
diimidazole), leading to the imine-amide intermediate
9. Addition of 5-fluorooxindole 10 to the crude reaction
mixture led to the target molecule.
Ea r ly Am id a tion Ap p r oa ch to
3-[(4-Am id o)p yr r ol-2-yl]-2-in d olin on es†
J erad M. Manley, Monica J . Kalman, Brian G. Conway,
Cynthia C. Ball, J effrey L. Havens, and
Rajappa Vaidyanathan*
The approach described in Scheme 1 relied on a late-
stage coupling of the pivotal pyrrole core 7 with diamine
8 and 5-fluorooxindole 10. An advantage of this strategy
was that it rendered the process amenable to the rapid
synthesis of several analogues. One could imagine treat-
ing pyrrole 7 with a variety of amines and substituted
oxindoles to afford a host of indolinones. However, this
approach had two important limitations from the stand-
point of commercial process development for compound
1. The amidation reaction had to be performed on an
activated carboxylic acid derivative. In such an event, the
presence of the aldehyde moiety led to the formation of
the imine in addition to the desired amide. While the
imine itself did not pose problems in the subsequent aldol
coupling step, its formation necessitated the use of excess
diamine in the amide formation step. This, although
acceptable in the case of inexpensive amines, was an
issue when more expensive amines were involved. Sub-
sequent removal of the excess amine could also prove
problematic. Moreover, of the several known amide
coupling reagents, very few (such as EDC and CDI) gave
satisfactory results. Removal of the byproducts (arising
from the activating agent) from these coupling reactions
could be problematic and should be carefully considered
while developing workup conditions. The use of these
activating agents was also undesirable from an atom
economy standpoint, since no portion of the reagent was
incorporated in the final molecule. These limitations
prompted us to examine alternate approaches to the
target compound.
Chemical Research and Development, Pfizer Inc.,
0200-1500-91-201, 7000 Portage Road,
Kalamazoo, Michigan 49001
rajappa.vaidyanathan@pfizer.com
Received March 7, 2003
Abstr a ct: A new synthesis of 3-[(4-amido)pyrrol-2-yl]-2-
indolinones has been developed, where the amide side chain
was installed prior to pyrrole formation. This strategy
precludes the need to use any coupling reagents to install
the amide side chain. This process includes a zinc-free
alternative to the Knorr pyrrole synthesis.
A number of indolinone derivatives have been known
to exhibit pharmaceutical activity. Specifically, com-
pounds containing an amide group on a heterocyclic ring
condensed with the indolinone have been shown to
modulate protein kinase activity. Such compounds could
possibly be used to treat a variety of conditions such as
various types of cancer, mastocystosis, allergy associated
chronic rhinitis, diabetes, arthritis, angiogenesis, im-
munological and cardiovascular disorders, etc. Of this
class of compounds, 1 is being investigated in phase I/II
clinical trials in cancer.1
We envisioned that the issue of excess diamine could
be resolved if one were to install the aldehyde moiety
after amide bond formation. Our new retrosynthetic
analysis is presented in Scheme 2, whereby the pyrrole
core may be assembled with the amide chain in place.
To synthesize pyrrole 11 via the Knorr reaction, one
would have to start from oxime 3 (derived from tert-butyl
acetoacetate) and â-ketoamide 12. This compound can be
made from diketene 13 and N,N-diethylethylenediamine
8. This approach would circumvent the need to use excess
amine, as well as amide coupling reagents. Our results
are discussed below.
Treatment of diketene with N,N-diethylethylenedi-
amine in tert-butyl methyl ether furnished â-ketoamide
12 in excellent yield (Scheme 3).4 The â-ketoamide was
prone to decomposition and, therefore, had to be either
used immediately or stored at -20 °C. The product was
typically contaminated with polymeric material that
carried over from diketene. However, this did not cause
any problems in the downstream chemistry. Oxime 3,
derived from tert-butyl acetoacetate, was treated with
The first-generation synthesis of this compound uti-
lized the approach depicted in Scheme 1 where the
pyrrole core was assembled via a Knorr pyrrole reaction
between oxime 3 and ethyl acetoacetate (4).2 tert-Butyl
acetoacetate 2 was treated with NaNO2/HOAc to give the
corresponding oxime 3, which was allowed to react with
ethyl acetoacetate 4 in the presence of zinc under the
classical Knorr pyrrole reaction conditions to furnish
pyrrole 5. This compound underwent facile decarboxy-
lation upon treatment with HCl to give the R-free pyrrole
6. Vilsmeier formylation followed by hydrolysis of the
† This paper is dedicated to the memory of Dr. Thomas J . Fleck.
(1) (a) Tang, P. C.; Miller, T.; Li, X.; Sun, L.; Wei, C. C.; Shirazian,
S.; Liang, C.; Vojkovsky, T.; Nematalla, A. S. WO 01/60814. (b) Mendel,
D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen, J . G.; Li, G.;
Schreck, R. E.; Abrams, T. J .; Ngai, T. J .; Lee, L. B.; Murray, L. J .;
Carver, J .; Chan, E.; Moss, K. G.; Haznedar, J . O.; Sukbuntherng, J .;
Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian, S.; McMahon,
G.; Cherrington, J . M. Clin. Cancer Res. 2003, 9, 327.
(3) de Groot, J . A.; Roy, G. M. G-L.; van Koveringe, J . A.;
Lugtenburg, J . Org. Prep. Proced. Int. 1981, 13, 97.
(4) Beholz, L. G.; Benovsky, P.; Ward, D. L.; Barta, N. S.; Stille, J .
R. J . Org. Chem. 1997, 62, 1033.
(2) (a) Fischer, H. Organic Syntheses; Wiley: New York, 1943;
Collect. Vol. II, p 202. (b) Treibs, A.; Hintermeier, K. Chem. Ber. 1954,
86, 1167.
10.1021/jo034304q CCC: $25.00 © 2003 American Chemical Society
Published on Web 07/11/2003
J . Org. Chem. 2003, 68, 6447-6450
6447